IBOV 177,866 ▲ 2.97% IPSA 11,057 ▲ 0.28% IPC MEX 66,496 ▲ 0.59% MERVAL 3,280,224 ▲ 2.43% COLCAP 2,307.67 ▲ 0.65% BVL PERÚ 56,194.27 ▲ 1.29% USD/BRL 5.11 — 0.00% USD/MXN17.48▲ 0.04% USD/CLP923.90▼ 0.41% USD/COP3,237▼ 0.27% USD/PEN3.41▲ 0.44% USD/ARS1,487▼ 0.03% USD/UYU40.22▲ 1.37% USD/PYG6,055▲ 1.45% USD/BOB10.14▲ 4.01% USD/DOP58.61▲ 0.22% USD/CRC448.82▲ 1.41% USD/GTQ7.63▲ 2.31% USD/HNL26.72▲ 0.09% USD/NIO 36.62 — 0.00% USD/VES719.54▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD158.09▲ 0.40% USD/TTD6.75▲ 1.44% EUR/BRL5.84▲ 0.34% BRENT 78.43 ▲ 3.18% WTI 73.75 ▲ 3.28% IRON ORE 161.91 — — COPPER 6.26 ▲ 0.47% GOLD 4,073 ▼ 0.76% SILVER 58.76 ▼ 1.75% SOY 1,199 ▲ 0.21% CORN 466.50 ▲ 6.51% WHEAT 638.75 ▲ 1.07% COFFEE 327.85 ▼ 4.42% SUGAR 14.68 ▼ 1.34% ORANGE JUICE 143.25 ▼ 4.44% COTTON 81.35 ▲ 1.79% COCOA 5,480 ▼ 7.42% BEEF 230.55 ▼ 2.00% CATTLE 354.60 ▼ 0.44% LITHIUM 72.32 ▼ 0.69% PETR4 39.65 ▲ 1.12% VALE3 74.18 ▲ 1.41% ITUB4 44.30 ▲ 4.02% BBDC4 18.86 ▲ 4.78% ABEV3 15.82 ▲ 0.64% BBAS3 20.58 ▲ 2.90% B3SA3 15.42 ▲ 4.26% WEGE3 46.51 ▲ 1.68% PRIO3 55.45 ▼ 0.29% SUZB3 41.55 ▲ 1.27% RENT3 41.10 ▲ 4.31% AZZA3 19.10 ▲ 3.47% CSAN3 4.07 ▲ 5.44% RAIZ4 0.35 ▼ 5.41% PCAR3 2.73 ▼ 1.09% GMAT3 3.97 ▲ 1.02% PSSA3 54.97 ▲ 3.04% CVCB3 1.25 — 0.00% POSI3 3.97 ▲ 3.12% SLCE3 14.02 ▲ 1.67% NATU3 8.68 ▲ 2.60% BRKM5 6.63 ▲ 4.25% RANI3 8.01 ▲ 1.91% CSNA3 5.18 ▲ 7.92% CMIN3 5.23 ▲ 8.28% USIM5 8.45 ▲ 1.20% GGBR4 23.01 ▲ 2.36% ENEV3 27.55 ▲ 5.15% CPFE3 47.87 ▲ 3.41% CMIG4 11.38 ▲ 2.71% EQTL3 40.91 ▲ 3.54% LREN3 14.62 ▲ 3.32% VIVT3 35.75 ▲ 3.62% RAIL3 14.36 ▲ 4.44% KLABIN 17.54 ▲ 0.80% RAIA DROGASIL 18.77 ▲ 3.53% RDOR3 36.02 ▲ 2.48% HAPV3 10.60 ▲ 5.26% FLRY3 16.42 ▲ 4.25% SMTO3 16.37 ▲ 1.99% UGPA3 30.71 ▲ 2.03% VBBR3 33.00 ▲ 2.80% BBSE3 40.35 ▲ 2.72% BPAC11 58.73 ▲ 5.48% CURY3 34.21 ▲ 4.62% AERI3 2.09 ▲ 1.46% VIVARA 23.53 ▲ 4.21% COMPASS 25.50 ▲ 3.32% VAMOS 3.06 ▲ 3.38% SANB11 27.62 ▲ 5.22% ASAI3 8.87 ▲ 4.85% SBSP3 31.11 ▲ 3.70% WALMEX 49.31 ▲ 0.59% GMEXICO 198.62 ▲ 1.68% FEMSA 223.20 ▲ 0.37% CEMEX 21.82 ▲ 0.51% GFNORTE 186.51 ▲ 0.63% BIMBO 56.06 ▲ 0.23% TELEVISA 9.74 ▲ 2.63% AMX 22.70 ▲ 0.27% GAP 412.01 ▼ 0.41% ASUR 285.12 ▲ 0.53% OMA 235.73 ▼ 0.95% KOF 182.08 ▲ 0.65% GRUMA 282.99 ▲ 0.14% KIMBER 38.13 ▼ 0.81% SQM-B 67,750 ▼ 1.95% COPEC 6,139 ▲ 1.98% BSANTANDER 79.00 ▲ 1.94% FALABELLA 5,905 ▲ 0.92% ENELAM 85.40 ▲ 1.47% CENCOSUD 2,045 ▼ 0.55% CMPC 1,109 ▲ 1.32% BANCO CHILE 188.88 ▲ 1.01% LATAM AIR 26.26 ▼ 0.53% YPF 74,450 ▼ 1.75% GGAL 8,350 ▲ 5.96% PAMPA 5,185 ▼ 0.38% TXAR 671.00 ▲ 0.98% ALUAR 978.00 ▲ 0.98% TGS 9,610 ▲ 3.22% CEPU 2,405 ▲ 3.89% MIRGOR 17,375 ▲ 1.02% COME 45.90 ▲ 1.06% LOMA NEGRA 3,583 ▲ 2.43% BYMA 314.00 ▲ 1.37% TELECOM ARG 4,248 ▲ 3.09% ECOPETROL 15.59 ▲ 1.27% BANCOLOMBIA 82.95 ▲ 2.50% GRUPO AVAL 5.08 ▲ 1.20% CREDICORP 400.81 ▲ 2.27% SOUTHERN COPPER 175.83 ▲ 0.80% BUENAVENTURA 30.00 ▲ 1.52% MERCADOLIBRE 1,852 ▲ 2.46% NUBANK 13.76 ▲ 0.66% XP 16.92 ▲ 3.11% PAGSEGURO 9.25 ▲ 2.78% STONE 11.21 ▲ 2.28% GLOBANT 29.96 ▼ 4.25% TECNOGLASS 43.90 ▲ 1.76% GAP AIRPORT 235.64 ▲ 0.50% ASUR 285.12 ▲ 0.53% OMA AIRPORT 108.09 ▼ 0.22% AMX ADR 26.04 ▲ 0.77% FEMSA ADR 127.70 ▲ 0.55% CEMEX ADR 12.48 ▲ 0.89% PETROBRAS ADR 17.32 ▲ 1.70% VALE ADR 14.46 ▲ 1.69% ITAU ADR 8.62 ▲ 4.11% SANTANDER BR 5.39 ▲ 4.86% AMBEV ADR 3.07 ▲ 0.99% CSN 1.01 ▲ 5.79% GERDAU 4.50 ▲ 2.04% LATAM ADR 56.45 ▼ 1.03% BTC 63,023 ▼ 1.15% ETH 1,781 ▼ 1.35% SOL 76.29 ▼ 0.76% XRP 1.08 ▼ 0.71% BNB 569.15 ▼ 0.84% ADA 0.16 ▼ 1.21% DOGE 0.07 ▼ 0.65% AVAX 6.63 ▲ 3.56% LINK 7.99 ▼ 0.09% DOT 0.84 ▼ 0.97% LTC 43.72 ▼ 0.57% BCH 238.30 ▼ 0.69% TRX 0.33 ▼ 0.49% XLM 0.18 ▼ 1.14% HBAR 0.07 ▼ 0.49% NEAR 1.92 ▲ 1.71% ATOM 1.55 ▼ 1.22% AAVE 96.34 ▼ 0.74% SELIC 14.25% EMBRAER 84.60 ▲ 0.88% EMBRAER ADR 66.01 ▲ 0.72% JBS 11.91 ▲ 1.53% JBS BDR 60.78 ▲ 1.22% MBRF3 15.55 ▲ 0.91% MBRFY 2.97 ▼ 1.00% INTER 5.82 ▲ 1.93% EGX 52,573 ▲ 0.61% USD/ZAR16.35▲ 0.18% USD/NGN 1,376 — 0.00% NIKKEI 67,243 ▼ 1.92% CSI300 4,695 ▼ 1.79% HSI 24,214 ▲ 0.16% NIFTY 24,211 ▲ 0.02% KOSPI 6,807 ▼ 8.95% JCI 6,038 ▲ 1.92% USD/JPY162.10▲ 0.23% USD/CNY6.78— 0.00% DAX 25,119 ▲ 0.21% CAC 8,343 ▲ 0.04% FTSE 10,492 ▼ 0.05% MIB 52,753 ▲ 0.26% IBEX 19,415 ▲ 0.16% STOXX 640.46 ▼ 0.10% EUR/USD1.14▲ 0.29% GBP/USD1.34▼ 0.01% SPX 7,575 ▲ 0.42% DJI 52,637 ▲ 0.29% NDX 29,825 ▲ 0.33% RUT 2,978 ▼ 0.49% TSX 35,305 ▲ 0.30% VIX 16.25 ▲ 8.12% USD/CAD1.41▼ 0.18% US10Y 4.5690 ▲ 0.66% IBOV 177,866 ▲ 2.97% IPSA 11,057 ▲ 0.28% IPC MEX 66,496 ▲ 0.59% MERVAL 3,280,224 ▲ 2.43% COLCAP 2,307.67 ▲ 0.65% BVL PERÚ 56,194.27 ▲ 1.29% USD/BRL 5.11 — 0.00% USD/MXN 17.48 ▲ 0.04% USD/CLP 923.90 ▼ 0.41% USD/COP 3,237 ▼ 0.27% USD/PEN 3.41 ▲ 0.44% USD/ARS 1,487 ▼ 0.03% USD/UYU 40.22 ▲ 1.37% USD/PYG 6,055 ▲ 1.45% USD/BOB 10.14 ▲ 4.01% USD/DOP 58.61 ▲ 0.22% USD/CRC 448.82 ▲ 1.41% USD/GTQ 7.63 ▲ 2.31% USD/HNL 26.72 ▲ 0.09% USD/NIO 36.62 — 0.00% USD/VES 719.54 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 158.09 ▲ 0.40% USD/TTD 6.75 ▲ 1.44% EUR/BRL 5.84 ▲ 0.34% BRENT 78.43 ▲ 3.18% WTI 73.75 ▲ 3.28% IRON ORE 161.91 — — COPPER 6.26 ▲ 0.47% GOLD 4,073 ▼ 0.76% SILVER 58.76 ▼ 1.75% SOY 1,199 ▲ 0.21% CORN 466.50 ▲ 6.51% WHEAT 638.75 ▲ 1.07% COFFEE 327.85 ▼ 4.42% SUGAR 14.68 ▼ 1.34% ORANGE JUICE 143.25 ▼ 4.44% COTTON 81.35 ▲ 1.79% COCOA 5,480 ▼ 7.42% BEEF 230.55 ▼ 2.00% CATTLE 354.60 ▼ 0.44% LITHIUM 72.32 ▼ 0.69% PETR4 39.65 ▲ 1.12% VALE3 74.18 ▲ 1.41% ITUB4 44.30 ▲ 4.02% BBDC4 18.86 ▲ 4.78% ABEV3 15.82 ▲ 0.64% BBAS3 20.58 ▲ 2.90% B3SA3 15.42 ▲ 4.26% WEGE3 46.51 ▲ 1.68% PRIO3 55.45 ▼ 0.29% SUZB3 41.55 ▲ 1.27% RENT3 41.10 ▲ 4.31% AZZA3 19.10 ▲ 3.47% CSAN3 4.07 ▲ 5.44% RAIZ4 0.35 ▼ 5.41% PCAR3 2.73 ▼ 1.09% GMAT3 3.97 ▲ 1.02% PSSA3 54.97 ▲ 3.04% CVCB3 1.25 — 0.00% POSI3 3.97 ▲ 3.12% SLCE3 14.02 ▲ 1.67% NATU3 8.68 ▲ 2.60% BRKM5 6.63 ▲ 4.25% RANI3 8.01 ▲ 1.91% CSNA3 5.18 ▲ 7.92% CMIN3 5.23 ▲ 8.28% USIM5 8.45 ▲ 1.20% GGBR4 23.01 ▲ 2.36% ENEV3 27.55 ▲ 5.15% CPFE3 47.87 ▲ 3.41% CMIG4 11.38 ▲ 2.71% EQTL3 40.91 ▲ 3.54% LREN3 14.62 ▲ 3.32% VIVT3 35.75 ▲ 3.62% RAIL3 14.36 ▲ 4.44% KLABIN 17.54 ▲ 0.80% RAIA DROGASIL 18.77 ▲ 3.53% RDOR3 36.02 ▲ 2.48% HAPV3 10.60 ▲ 5.26% FLRY3 16.42 ▲ 4.25% SMTO3 16.37 ▲ 1.99% UGPA3 30.71 ▲ 2.03% VBBR3 33.00 ▲ 2.80% BBSE3 40.35 ▲ 2.72% BPAC11 58.73 ▲ 5.48% CURY3 34.21 ▲ 4.62% AERI3 2.09 ▲ 1.46% VIVARA 23.53 ▲ 4.21% COMPASS 25.50 ▲ 3.32% VAMOS 3.06 ▲ 3.38% SANB11 27.62 ▲ 5.22% ASAI3 8.87 ▲ 4.85% SBSP3 31.11 ▲ 3.70% WALMEX 49.31 ▲ 0.59% GMEXICO 198.62 ▲ 1.68% FEMSA 223.20 ▲ 0.37% CEMEX 21.82 ▲ 0.51% GFNORTE 186.51 ▲ 0.63% BIMBO 56.06 ▲ 0.23% TELEVISA 9.74 ▲ 2.63% AMX 22.70 ▲ 0.27% GAP 412.01 ▼ 0.41% ASUR 285.12 ▲ 0.53% OMA 235.73 ▼ 0.95% KOF 182.08 ▲ 0.65% GRUMA 282.99 ▲ 0.14% KIMBER 38.13 ▼ 0.81% SQM-B 67,750 ▼ 1.95% COPEC 6,139 ▲ 1.98% BSANTANDER 79.00 ▲ 1.94% FALABELLA 5,905 ▲ 0.92% ENELAM 85.40 ▲ 1.47% CENCOSUD 2,045 ▼ 0.55% CMPC 1,109 ▲ 1.32% BANCO CHILE 188.88 ▲ 1.01% LATAM AIR 26.26 ▼ 0.53% YPF 74,450 ▼ 1.75% GGAL 8,350 ▲ 5.96% PAMPA 5,185 ▼ 0.38% TXAR 671.00 ▲ 0.98% ALUAR 978.00 ▲ 0.98% TGS 9,610 ▲ 3.22% CEPU 2,405 ▲ 3.89% MIRGOR 17,375 ▲ 1.02% COME 45.90 ▲ 1.06% LOMA NEGRA 3,583 ▲ 2.43% BYMA 314.00 ▲ 1.37% TELECOM ARG 4,248 ▲ 3.09% ECOPETROL 15.59 ▲ 1.27% BANCOLOMBIA 82.95 ▲ 2.50% GRUPO AVAL 5.08 ▲ 1.20% CREDICORP 400.81 ▲ 2.27% SOUTHERN COPPER 175.83 ▲ 0.80% BUENAVENTURA 30.00 ▲ 1.52% MERCADOLIBRE 1,852 ▲ 2.46% NUBANK 13.76 ▲ 0.66% XP 16.92 ▲ 3.11% PAGSEGURO 9.25 ▲ 2.78% STONE 11.21 ▲ 2.28% GLOBANT 29.96 ▼ 4.25% TECNOGLASS 43.90 ▲ 1.76% GAP AIRPORT 235.64 ▲ 0.50% ASUR 285.12 ▲ 0.53% OMA AIRPORT 108.09 ▼ 0.22% AMX ADR 26.04 ▲ 0.77% FEMSA ADR 127.70 ▲ 0.55% CEMEX ADR 12.48 ▲ 0.89% PETROBRAS ADR 17.32 ▲ 1.70% VALE ADR 14.46 ▲ 1.69% ITAU ADR 8.62 ▲ 4.11% SANTANDER BR 5.39 ▲ 4.86% AMBEV ADR 3.07 ▲ 0.99% CSN 1.01 ▲ 5.79% GERDAU 4.50 ▲ 2.04% LATAM ADR 56.45 ▼ 1.03% BTC 63,023 ▼ 1.15% ETH 1,781 ▼ 1.35% SOL 76.29 ▼ 0.76% XRP 1.08 ▼ 0.71% BNB 569.15 ▼ 0.84% ADA 0.16 ▼ 1.21% DOGE 0.07 ▼ 0.65% AVAX 6.63 ▲ 3.56% LINK 7.99 ▼ 0.09% DOT 0.84 ▼ 0.97% LTC 43.72 ▼ 0.57% BCH 238.30 ▼ 0.69% TRX 0.33 ▼ 0.49% XLM 0.18 ▼ 1.14% HBAR 0.07 ▼ 0.49% NEAR 1.92 ▲ 1.71% ATOM 1.55 ▼ 1.22% AAVE 96.34 ▼ 0.74% SELIC 14.25% EMBRAER 84.60 ▲ 0.88% EMBRAER ADR 66.01 ▲ 0.72% JBS 11.91 ▲ 1.53% JBS BDR 60.78 ▲ 1.22% MBRF3 15.55 ▲ 0.91% MBRFY 2.97 ▼ 1.00% INTER 5.82 ▲ 1.93% EGX 52,573 ▲ 0.61% USD/ZAR 16.36 ▲ 0.06% USD/NGN 1,376 — 0.00% NIKKEI 67,243 ▼ 1.92% CSI300 4,695 ▼ 1.79% HSI 24,214 ▲ 0.16% NIFTY 24,211 ▲ 0.02% KOSPI 6,807 ▼ 8.95% JCI 6,038 ▲ 1.92% USD/JPY 162.12 ▲ 0.28% USD/CNY 6.7652 ▼ 0.02% DAX 25,119 ▲ 0.21% CAC 8,343 ▲ 0.04% FTSE 10,492 ▼ 0.05% MIB 52,753 ▲ 0.26% IBEX 19,415 ▲ 0.16% STOXX 640.46 ▼ 0.10% EUR/USD 1.1432 ▲ 0.11% GBP/USD 1.3384 ▼ 0.10% SPX 7,575 ▲ 0.42% DJI 52,637 ▲ 0.29% NDX 29,825 ▲ 0.33% RUT 2,978 ▼ 0.49% TSX 35,305 ▲ 0.30% VIX 16.25 ▲ 8.12% USD/CAD 1.4138 ▼ 0.10% US10Y 4.5690 ▲ 0.66%
since 2009
Monday, July 13, 2026

Covid-19: Updated count of reported injuries and deaths after vaccines in EU member states (January 29)

By · February 7, 2022 · 5 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – EudraVigilance, the European database where adverse reactions to vaccines are reported, had collected as of January 29; 38,983 reports of deaths and 3,530,362 reports of injuries (half of them serious) from people who received some of the four experimental injections licensed at this time within the member countries of the European Union.

In the previous report, dated January 1, the number of reported deaths was 36,257, and injuries were 3,244,052.

One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →

EudraVigilance is widely acknowledged to be vastly underreported. The effective case numbers are therefore likely to be significantly higher.

Read also: Check out our coverage on curated alternative narratives

EudraVigilance was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects. These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and pharmaceutical companies that hold marketing authorizations (licenses) for drugs.

Through January 29, 2022, its report lists 38,983 reports of deaths and 33,530,362 reports of injuries following injections with any of the four experimental vaccines currently approved in the EU.

MODERNA – COVID-19 mRNA VACCINE (CX-024414)
PFIZER-BioNTech – COVID-19 mRNA VACCINE
ASTRAZENECA – COVID-19 VACCINE (CHADOX1 NCOV-19)
JANSSEN – COVID-19 VACCINE (AD26.COV2.S )

Of the total number of registered injuries, almost half (1,672,872) are severe injuries*.

*According to Eudravigilance, “seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical event that results in death, is life-threatening, requires hospitalization, results in another medically important condition, or prolongs existing hospitalization, results in persistent or significant disability or incapacity, or is a congenital anomaly/congenital disability.”

RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

As we have discussed in previous reports, we have the following information thanks to a subscriber to the Health Impact News website in Europe, who is undertaking the work of expanding on the details in the reports of each of the four COVID-19 injections that we include here.

This subscriber volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and deaths, as there is no place in the EudraVigilance system to tabulate all the results.

It should be noted that, just as not all reported deaths and injuries need necessarily be vaccine-related, it is well known that these reports represent a very minimal amount of the actual cases, as most death and injury events are not being reported.

We want to recommend once again reading the analysis ( (in French, please use online translator) made by Laurent Mucchielli, research director of the French National Center for Scientific Research (CNRS), who reviewed several databases of adverse event reports to COVID vaccines worldwide and ended up launching an alert directly to all: “We are facing an unprecedented mortality, and a moratorium must be put on this vaccination”.

Here are the EudraVigilance data summarized up to November 20, 2021.

Total reactions for the Pfizer/BioNTech vaccine:
17,578 deaths and 1,704,757 injuries.
a 29/01/2022

  • 48,240 Blood and lymphatic system disorders incl. 242 deaths
  • 57,541 Cardiac disorders incl. 2,554 deaths
  • 522 Congenital, familial, and genetic disorders incl. 51 deaths
  • 22,590 Ear and labyrinth disorders incl. 11 deaths
  • 1,911 Endocrine disorders incl. 6 deaths
  • 25,814 Ocular disorders incl. 38 deaths
  • 133,365 Gastrointestinal disorders incl. 681 deaths
  • 422,360 General disorders and administration site conditions incl. 5,024 deaths
  • 1,931 Hepatobiliary disorders incl. 90 deaths
  • 18,455 Immune system disorders incl. 95 deaths
  • 76,443 Infections and infestations incl. 1,878 deaths
  • 33,972 Injuries, poisoning, and procedural complications, incl. 331 deaths
  • 42,585 Investigations incl. 502 deaths
  • 11,344 Metabolic and nutritional disorders, incl. 273 deaths
  • 201,643 Musculoskeletal and connective tissue disorders, incl. 212 deaths
  • 1,629 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) incl. 153 deaths
  • 278,744 Nervous system disorders incl. 1,859 deaths
  • 2,513 Pregnancy, puerperium and perinatal conditions incl. 74 deaths
  • 251 Product problems incl. 3 deaths
  • 30,622 Psychiatric disorders incl. 207 deaths
  • 6,150 Renal and urinary disorders incl. 266 deaths
  • 68,129 Reproductive system and breast disorders incl. 6 deaths
  • 72,531 Respiratory, thoracic and mediastinal disorders incl. 1,884 deaths
  • 78,059 Disorders of skin and subcutaneous tissue incl. 146 deaths
  • 3,871 Social circumstances incl. 22 deaths
  • 21,010 Surgical and medical procedures incl. 204 deaths
  • 42,532 Vascular disorders incl. 766 deaths

Total reactions to the Moderna vaccine:
11,008 deaths and 543,543 injuries
a 29/01/2022

  • 12,365 Blood and lymphatic system disorders incl. 120 deaths
  • 18,287 Cardiac disorders incl. 1,142 deaths
  • 190 Congenital, familial, and genetic disorders incl. 11 deaths
  • 6,310 Hearing and labyrinth disorders incl. 8 deaths
  • 502 Endocrine disorders, incl. 6 deaths
  • 7,475 Eye disorders incl. 36 deaths
  • 44,340 Gastrointestinal disorders incl. 413 deaths
  • 145,153 General disorders and conditions at site of administration incl. 3,630 deaths
  • 793 Hepatobiliary disorders incl. 54 deaths
  • 5,370 Immune system disorders incl. 22 deaths
  • 23,070 Infections and infestations incl. 1042 deaths
  • 10,286 Injuries, intoxications and procedural complications, incl. 208 deaths
  • 12,129 Investigations incl. 393 deaths
  • 4,847 Disorders of metabolism and nutrition incl. 263 deaths
  • 66,358 Musculoskeletal and connective tissue disorders incl. 223 deaths
  • 682 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) , incl. 85 deaths
  • 91,230 Nervous system disorders, incl. 1,029 deaths
  • 907 Pregnancy, puerperium and perinatal conditions, incl. 10 deaths
  • 98 Product problems incl. 4 deaths
  • 9,441 Psychiatric disorders incl. 181 deaths
  • 3,030 Kidney and urinary disorders, incl. 214 deaths
  • 12,547 Reproductive system and breast disorders incl. 9 deaths
  • 23,251 Respiratory, thoracic and mediastinal disorders incl. 1,162 deaths
  • 27,540 Disorders of skin and subcutaneous tissue incl. 96 deaths
  • 2,239 Social circumstances incl. 45 deaths
  • 3,028 Surgical and medical procedures incl. 203 deaths
  • 12,075 Vascular disorders incl. 399 deaths

Total reactions for the Oxford/AstraZeneca vaccine:
7,977 deaths and 1,154,757 injuries.
a 29/01/2022

  • 13,912 Blood and lymphatic system disorders, incl. 278 deaths
  • 20,984 Cardiac disorders incl. 830 deaths
  • 235 Familial and genetic congenital disorders, incl. 8 deaths
  • 13,406 Hearing and labyrinth disorders incl. 7 deaths
  • 692 Endocrine disorders incl. 6 deaths
  • 20,086 Ocular disorders incl. 32 deaths
  • 107,453 Gastrointestinal disorders incl. 434 deaths
  • 304,993 General disorders and conditions at site of administration incl. 1,855 deaths
  • 1,039 Hepatobiliary disorders incl. 69 deaths
  • 5,409 Immune system disorders incl. 40 deaths
  • 42,266 Infections and infestations incl. 620 deaths
  • 13,630 Poisoning from injuries and procedural complications, incl. 198 deaths
  • 25,681 Investigations incl. 205 deaths
  • 13,023 Disorders of metabolism and nutrition incl. 126 deaths
  • 168,174 Musculoskeletal and connective tissue disorders incl. 165 deaths
  • 743 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) , incl. 40 deaths
  • 234,117 Nervous system disorders, incl. 1,178 deaths
  • 635 Pregnancy puerperium and perinatal conditions incl. 20 deaths
  • 199 Product problems incl. 1 death
  • 21,051 Psychiatric disorders incl. 69 deaths
  • 4,338 Renal and urinary disorders incl. 78 deaths
  • 16,849 Reproductive system and breast disorders incl. 3 deaths
  • 41,401 Respiratory, thoracic and mediastinal disorders incl. 1,082 deaths
  • 52,064 Skin and subcutaneous tissue disorders incl. 65 deaths
  • 1,617 Social circumstances incl. 9 deaths
  • 1,973 Surgical and medical procedures incl. 30 deaths28,787 Vascular disorders incl. 529 deaths

Total reactions for the Johnson & Johnson vaccine:
2,420 deaths and 127,305 injuries
a 29/01/2022

  • 1,229 Blood and lymphatic system disorders incl. 51 deaths
  • 2,552 Cardiac disorders incl. 204 deaths
  • 40 Congenital, familial, and genetic disorders incl. 1 death
  • 1,319 Hearing and labyrinth disorders incl. 3 deaths
  • 105 Endocrine disorders incl. 1 death
  • 1,656 Ocular disorders incl. 10 deaths
  • 9,588 Gastrointestinal disorders incl. 88 deaths
  • 34,487 General disorders and conditions at the site of administration incl. 685 deaths
  • 153 Hepatobiliary disorders incl. 13 deaths
  • 544 Immune system disorders, incl. 10 deaths
  • 8,521 Infections and infestations incl. 207 deaths
  • 1,147 Injuries, intoxications and procedural complications, incl. 25 deaths
  • 6,086 Investigations incl. 131 deaths
  • 756 Disorders of metabolism and nutrition, incl. 60 deaths
  • 17,116 Musculoskeletal and connective tissue disorders, incl. 55 deaths
  • 86 Benign, malignant and unspecified neoplasms (incl. cysts and polyps) , incl. 8 deaths
  • 23,413 Nervous system disorders incl. 245 deaths
  • 55 Pregnancy, puerperium and perinatal conditions incl. 1 death
  • 30 Product problems
  • 1,766 Psychiatric disorders incl. 22 deaths
  • 535 Renal and urinary disorders incl. 31 deaths
  • 2,941 Reproductive system and breast disorders incl. 6 deaths
  • 4,468 Respiratory, thoracic and mediastinal disorders incl. 304 deaths
  • 3,760 Skin and subcutaneous tissue disorders incl. 10 deaths
  • 409 Social circumstances incl. 4 deaths
  • 867 Medical and surgical procedures, incl. 74 deaths
  • 3,676 Vascular disorders incl. 171 deaths

This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.

Join us on Telegram: t.me/theriotimes

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.